USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: LIMAGING, LLC
City: CLARKSVILLE
State: MD
Zip+4: 21029-1690
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $252,361.00 2
SBIR Phase II $1,115,524.00 2

Award List:

MobileTran: A Handheld Sign Translation Apps for Warfighters

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency / Branch: DOD / DARPA
Principal Investigator: Huiping Li, President
Award Amount: $98,597.00
Abstract:
When the United States military commits to operations in foreign territories, it is important for soldiers to have the ability to understand textual information they encounter accurately and in a timely manner. For this SBIR Limaging proposes to develop a document and sign translation system that… More

MOBILE EMEDMINDER: A NETWORKED AIDE FOR MEDICATION COMPLIANCE

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: HHS
Principal Investigator: Huiping Li
Award Amount: $615,725.00
Abstract:
Not Available

DBillScan: A Camera Phone Based Currency Reader for the Visually Impaired

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Huiping Li – 301-728-0694
Award Amount: $153,764.00
Abstract:
DESCRIPTION (provided by applicant): For this SBIR Limaging, LLC teams with researchers in Ophthalmology at the Wilmer Eye Institute at Johns Hopkins University to develop DBillScan, a camera phone based currency reader to identify U.S. dollar bills for the blind and visual impaired (VI). In many… More

TAS::75 0894::TAS SBIR PHASE II (PHS 2008-1,TOPIC 33 ) LIMAGING, LLC

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: Huiping Li – 301-728-0694
Award Amount: $499,799.00
Abstract:
Under Phase I of the project (SBIR PHS 2008-1, "Development of Methodology for Measuring and Enhancing Compliance for Medications, Topic 33), the MobileMedMinder was successfully demonstrated. Phase II will involve collaboration to develop and commercialize the MobileMedMinder. This product… More